The EP3 Agonist Sulprostone Enhances Platelet Adhesion But Not Thrombus Formation Under Flow Conditions

被引:10
作者
Pasterk, Lisa [1 ]
Philipose, Sonia [1 ]
Eller, Kathrin [2 ]
Marsche, Gunther [1 ]
Heinemann, Akos [1 ]
Schuligoi, Rufina [1 ]
机构
[1] Med Univ Graz, Inst Expt & Clin Pharmacol, AT-8010 Graz, Austria
[2] Med Univ Graz, Clin Div Nephrol, Dept Internal Med, AT-8010 Graz, Austria
基金
奥地利科学基金会;
关键词
Platelet adhesion; Prostaglandin EP3 receptor; Thrombus formation under flow; PROSTANOID RECEPTORS; PROSTAGLANDIN E-2; MICE LACKING; HUMAN BLOOD; CYCLIC AMP; AGGREGATION; PGE(2); ACTIVATION; COLLAGEN; INHIBITION;
D O I
10.1159/000437143
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Platelets express the EP2, EP3 and EP4 receptors. Prostaglandin (PG) E-2 has a biphasic effect on platelets. Low concentrations of PGE(2) enhance platelet aggregation through the activation of the EP3 receptors, while at high concentrations it attenuates aggregation via the EP4 receptor. Consequently, EP3 receptor inhibition was shown to inhibit artherothrombosis, but had no influence on bleeding time in vivo. In this study, we investigated the role of the EP3 receptor in adhesion and thrombus formation under flow conditions in vitro. The EP3 agonist sulprostone caused an increase in the adhesion of washed platelets to fibrinogen as well as to collagen under low shear stress, an effect that was blocked by the EP3 antagonist L-798106. In contrast, when whole blood was perfused over collagen-coated surfaces, sulprostone did not enhance binding and thrombus formation of platelets on collagen; at high concentrations it even attenuated this response. We conclude that in more physiological models of thrombus formation, the role for EP3 receptors is limited, indirectly suggesting that the primary action of PGE(2) in haemostasis might be an inhibitory one. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:137 / 143
页数:7
相关论文
共 31 条
  • [1] Von Willebrand factor present in fibrillar collagen enhances platelet adhesion to collagen and collagen-induced platelet aggregation
    Bernardo, A
    Bergeron, AL
    Sun, CW
    Guchhait, P
    Cruz, MA
    López, JA
    Dong, JF
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (04) : 660 - 669
  • [2] Prostanoids and prostanoid receptors in signal transduction
    Bos, CL
    Richel, DJ
    Ritsema, T
    Peppelenbosch, MP
    Versteeg, HH
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (07) : 1187 - 1205
  • [3] Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation
    Fabre, JE
    Nguyen, M
    Athirakul, K
    Coggins, K
    McNeish, JD
    Austin, S
    Parise, LK
    FitzGerald, GA
    Coffman, TM
    Koller, BH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (05) : 603 - 610
  • [4] Effects on platelet function of an EP3 receptor antagonist used alone and in combination with a P2Y12 antagonist both in-vitro and ex-vivo in human volunteers
    Fox, S. C.
    May, J. A.
    Johnson, A.
    Hermann, D.
    Strieter, D.
    Hartman, D.
    Heptinstall, S.
    [J]. PLATELETS, 2013, 24 (05) : 392 - 400
  • [5] PGE2 reverses Gs-mediated inhibition of platelet aggregation by interaction with EP3 receptors, but adds to non-Gs-mediated inhibition of platelet aggregation by interaction with EP4 receptors
    Glenn, Jacqueline R.
    White, Ann E.
    Iyu, David
    Heptinstall, Stan
    [J]. PLATELETS, 2012, 23 (05) : 344 - 351
  • [6] GRESELE P, 1988, J PHARMACOL EXP THER, V246, P301
  • [7] Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors
    Gross, Sabrina
    Tilly, Peggy
    Hentsch, Didier
    Vonesch, Jean-Luc
    Fabre, Jean-Etienne
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (02) : 311 - 320
  • [8] DG-041 inhibits the EP3 prostanoid receptorA new target for inhibition of platelet function in atherothrombotic disease
    Heptinstall, Stan
    Espinosa, David Iyu
    Manolopoulos, Panagiotis
    Glenn, Jackie R.
    White, Ann E.
    Johnson, Andrew
    Dovlatova, Natalia
    Fox, Sue C.
    May, Jane A.
    Hermann, David
    Magnusson, Olafur
    Stefansson, Kari
    Hartman, Dan
    Gurney, Mark
    [J]. PLATELETS, 2008, 19 (08) : 605 - 613
  • [9] Reciprocal regulation of human platelet function by endogenous prostanoids and through multiple prostanoid receptors
    Hubertus, Katharina
    Mischnik, Marcel
    Timmer, Jens
    Herterich, Sabine
    Mark, Regina
    Moulard, Maxime
    Walter, Ulrich
    Geiger, Joerg
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 740 : 15 - 27
  • [10] PGE1 and PGE2 modify platelet function through different prostanoid receptors
    Iyu, David
    Juettner, Madlen
    Glenn, Jackie R.
    White, Ann E.
    Johnson, Andrew J.
    Fox, Susan C.
    Heptinstall, Stan
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2011, 94 (1-2) : 9 - 16